Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Furin

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 6, 2021
Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South AfricaM Loveday, H Cox, D Evans, et al.
Public Health Action|June 23, 2022
Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South AfricaB Memani, B Beko, N Dumile, et al.
IJTLD Open|December 15, 2025
The time is now: making the case for compassionate use/pre-approval access to new TB drugsA Reuter, J Stillo, S S Thi, et al.
Culture, Medicine and Psychiatry|September 22, 2009
Knowledge, attitudes, and practices of physicians in Tomsk Oblast tuberculosis services regarding alcohol use among tuberculosis patients in Tomsk, RussiaTrini A Mathew, Alan L Shields, Aizhan Imasheva, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 28, 2006
Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TBM L Rich, A R Socci, C D Mitnick, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 29, 2000
Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosisM C Becerra, J Freeman, J Bayona, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 6, 2003
Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosisS S Shin, A M Hyson, C Castañeda, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 28, 2018
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessmentI Monedero-Recuero, L Hernando-Marrupe, A Sánchez-Montalvá, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 27, 2001
Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosisJ J Furin, C D Mitnick, S S Shin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 15, 2020
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, IndiaM Das, F Mamnoon, H Mansoor, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 6, 2021
Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South AfricaM Loveday, H Cox, D Evans, et al.
Public Health Action|June 23, 2022
Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South AfricaB Memani, B Beko, N Dumile, et al.
IJTLD Open|December 15, 2025
The time is now: making the case for compassionate use/pre-approval access to new TB drugsA Reuter, J Stillo, S S Thi, et al.
Culture, Medicine and Psychiatry|September 22, 2009
Knowledge, attitudes, and practices of physicians in Tomsk Oblast tuberculosis services regarding alcohol use among tuberculosis patients in Tomsk, RussiaTrini A Mathew, Alan L Shields, Aizhan Imasheva, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 28, 2006
Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TBM L Rich, A R Socci, C D Mitnick, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 29, 2000
Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosisM C Becerra, J Freeman, J Bayona, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 6, 2003
Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosisS S Shin, A M Hyson, C Castañeda, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 28, 2018
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessmentI Monedero-Recuero, L Hernando-Marrupe, A Sánchez-Montalvá, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 27, 2001
Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosisJ J Furin, C D Mitnick, S S Shin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 15, 2020
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, IndiaM Das, F Mamnoon, H Mansoor, et al.
Pageof 9